Pamidronate Disodium (American Regent, Inc.)
Welcome to the PulseAid listing for the Pamidronate Disodium drug offered from American Regent, Inc.. This Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | American Regent, Inc. |
NON-PROPRIETARY NAME: | Pamidronate Disodium |
SUBSTANCE NAME: | PAMIDRONATE DISODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2010-07-16 |
END MARKETING DATE: | 0000-00-00 |
Pamidronate Disodium HUMAN PRESCRIPTION DRUG Details:
Item Description | Pamidronate Disodium from American Regent, Inc. |
LABELER NAME: | American Regent, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 3(mg/mL) |
START MARKETING DATE: | 2010-07-16 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0517-0745_dad40790-a202-4522-bda4-49195ef86bca |
PRODUCT NDC: | 0517-0745 |
APPLICATION NUMBER: | ANDA078942 |
Other PAMIDRONATE DISODIUM Pharmaceutical Manufacturers / Labelers: